Alkem Labs Acquires 79.37 Cr Shares in Subsidiary Alkem Medtech

Alkem Laboratories Ltd has acquired 79,36,50,794 equity shares in its wholly-owned subsidiary, Alkem Medtech Private Limited, through a rights issue. The acquisition was made at an issue price of ₹13.86 per share, aggregating to ₹11,00,00,00,005. Alkem Medtech, incorporated in March 2024, operates in the medical device segment, focusing on cardiovascular and orthopedic fields. For the financial year ended March 31, 2026, Alkem Medtech reported a turnover of ₹15.13 crores. This acquisition is part of Alkem Laboratories' strategy to acquire between 51% and 55% of the total issued equity share capital of M/s. Occlutech Holding AG. The transaction was completed on July 15, 2026, with cash consideration.